ES2571865T3 - Acilasas de beta-lactama de tipo II mutantes - Google Patents

Acilasas de beta-lactama de tipo II mutantes

Info

Publication number
ES2571865T3
ES2571865T3 ES14173437T ES14173437T ES2571865T3 ES 2571865 T3 ES2571865 T3 ES 2571865T3 ES 14173437 T ES14173437 T ES 14173437T ES 14173437 T ES14173437 T ES 14173437T ES 2571865 T3 ES2571865 T3 ES 2571865T3
Authority
ES
Spain
Prior art keywords
seq
acylase
type
beta
lactam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14173437T
Other languages
English (en)
Inventor
Der Laan Jan Metske Van
Richard Kerkman
Willem Bijleveld
Bianca Elisabeth Maria Gielesen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centrient Pharmaceuticals Netherlands BV
Original Assignee
DSM Sinochem Pharmaceuticals Netherlands BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM Sinochem Pharmaceuticals Netherlands BV filed Critical DSM Sinochem Pharmaceuticals Netherlands BV
Application granted granted Critical
Publication of ES2571865T3 publication Critical patent/ES2571865T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Una acilasa de beta-lactama de tipo II mutante seleccionada del grupo que consiste en la acilasa SE83-acil de Pseudomonas según se representa en la SEQ ID NO: 1, N176 de Brevundimonas diminuta según se representa en la SEQ ID NO: 2 y la acilasa V22 de Brevundimonas diminuta según se representa en la SEQ ID NO: 3, y polipéptidos con actividad de acilasa de beta-lactama de tipo II que tienen una secuencia de aminoácidos que es al menos un 90% idéntica a lo largo de toda su longitud con SEQ ID NO: 1, SEQ ID NO: 2 o SEQ ID NO: 3, en donde dicha acilasa de beta-lactama de tipo II mutante se caracteriza por que leucina en la posición 161 ha sido modificada en glicina, serina o treonina.
ES14173437T 2005-12-28 2006-12-28 Acilasas de beta-lactama de tipo II mutantes Active ES2571865T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05113024 2005-12-28

Publications (1)

Publication Number Publication Date
ES2571865T3 true ES2571865T3 (es) 2016-05-27

Family

ID=36584602

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14173437T Active ES2571865T3 (es) 2005-12-28 2006-12-28 Acilasas de beta-lactama de tipo II mutantes

Country Status (6)

Country Link
EP (2) EP2851423B1 (es)
KR (1) KR20080084986A (es)
CN (1) CN101351549B (es)
BR (1) BRPI0621278A2 (es)
ES (1) ES2571865T3 (es)
WO (1) WO2007073947A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103060298B (zh) * 2012-12-31 2014-07-02 安徽丰原基因工程技术有限公司 一种头孢菌素c酰化酶突变体及其编码基因与应用
KR101985911B1 (ko) * 2017-12-28 2019-06-04 아미코젠주식회사 Achromobacter sp. CCM 4824 유래 페니실린 G 아실라제 변이체 및 이의 이용
CN109055475A (zh) * 2018-08-03 2018-12-21 菏泽睿智科技开发有限公司 一种粪产碱杆菌的新用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003894A (en) 1971-08-17 1977-01-18 Gist-Brocades N.V. Preparation of 7-substituted amino-desacetoxycephalosporanic acid compounds
IE910956A1 (en) 1990-03-23 1991-09-25 Gist Brocades Nv A method of modulating the production of secondary¹metabolites
WO1991016435A1 (en) 1990-04-18 1991-10-31 Gist-Brocades N.V. Mutated beta-lactam acylase genes
US5318896A (en) 1991-09-11 1994-06-07 Merck & Co., Inc. Recombinant expandase bioprocess for preparing 7-aminodesacetoxy cephalosporanic acid (7-ADCA)
GB9204439D0 (en) * 1992-02-27 1992-04-15 Fujisawa Pharmaceutical Co A new cephalosporin c acylase
CN1087780C (zh) 1993-07-30 2002-07-17 吉斯特·布罗卡迪斯公司 通过3-(羧乙硫基)丙酰-7-adca有效生产7-adca的方法
WO1995004148A1 (en) 1993-07-30 1995-02-09 Gist-Brocades B.V. Process for the efficient production of 7-adca via 2-(carboxyethylthio)acetyl-7-adca and 3-(carboxymethylthio)propionyl-7-adca
TW400384B (en) 1993-11-01 2000-08-01 Fujisawa Pharmaceutical Co A new cephalosporin C acylase
GB9424945D0 (en) * 1994-12-09 1995-02-08 Fujisawa Pharmaceutical Co A new cephalosporin C acylase
ATE417100T1 (de) 1995-07-18 2008-12-15 Dsm Ip Assets Bv Eine verbesserte immobilisierte penicillin g acylase
ZA983396B (en) 1997-04-22 1998-10-27 Gist Brocades Bv A method for controlling the solubility of a beta-lactam nucleus
CN1795197B (zh) 2003-05-28 2010-06-02 帝斯曼知识产权资产管理有限公司 头孢菌素类化合物
KR100530299B1 (ko) 2003-08-11 2005-11-22 산도즈 게엠베하 변이 세팔로스포린 c 아실라제 및 이를 이용한 7-aca 제조방법
ITMI20040016A1 (it) 2004-01-12 2004-04-12 Antibiotics S P A Cefalosporina c acilasi

Also Published As

Publication number Publication date
CN101351549A (zh) 2009-01-21
CN101351549B (zh) 2013-03-20
EP1974029A2 (en) 2008-10-01
EP2851423A1 (en) 2015-03-25
BRPI0621278A2 (pt) 2011-12-06
HK1128305A1 (en) 2009-10-23
KR20080084986A (ko) 2008-09-22
WO2007073947A3 (en) 2007-11-08
EP2851423B1 (en) 2016-03-02
WO2007073947A2 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
HRP20090245T1 (en) Pyy agonists and uses thereof
ATE462006T1 (de) Isoform des vegfs
MX345513B (es) Polipeptidos variantes de exoamilasa.
DK1263941T3 (da) Xylanasevarianter med ændret sensitivitet overfor xylanaseinhibitorer
ES2691539T3 (es) Luciferasas de Oplophorus sintéticas con mayor emisión de luz
AR120891A1 (es) Proteína rsv f mutante y su uso
DK1654355T3 (da) Pseudomonas polypeptidvarianter med ikke-maltogen exoamylaseaktivitet og deres anvendelse til fremstilling af fødevarer
PT1692281E (pt) Identificação de uma mutação de jak2 implicada na poliglobulia de vaquez
DK1440709T3 (da) Kombinationer, der omfatter cGMP PDE5 inhibitorer
DE60326259D1 (de) Neue fructosylpeptidoxidase und deren nutzung
DE60020943D1 (de) HYDANTOINASE-VARIANTEN MIT VERBESSERTEN EIGENSCHAFTEN UND IHRE ANWENDUNG ZUR PRODUKTION VON AMINOSäUREN
ATE278710T1 (de) Antimikrobiell wirksame peptide
ES2531372T3 (es) Enzimas de procesamiento fusionadas a marcadores de proteínas básicas
BR0117083A (pt) Meio de processamento para prender uma parte de uma carroceria de veìculo
DE60013939D1 (de) Stereoselektive Transaminase, deren kodierende Gen und deren Verwendungen
MX2007000334A (es) Polipeptido.
ATE389013T1 (de) Faktor x-analoge mit verbesserter fähigkeit zur aktivierung
ATE399865T1 (de) Rekombinante d-aminosäure-oxidase
WO2007030577A3 (en) Prodrugs of t3 and t4 with enhanced bioavailability
ATE469896T1 (de) Aminosäuresalze von rosiglitazon
DK0942992T3 (da) O-fucosyltransferase
NZ583429A (en) Peptides and proteins capable of inhibiting and/or preventing mast cell activation
DK1664102T3 (da) Isoleret photoprotein mtclytin, samt dets anvendelse
DE60329115D1 (de) Tumorantigenprotein und dessen verwendung
NO20081503L (no) T-celle adhesjonsmolekyl, og antistoff dertil